PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia.

Mouse / Haemorrhage/shock

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28007523 ↗2016Reported benefit

Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia.

MouseHaemorrhage/shockUnspecifiedMaleOptimal dose 5 mg/kg; a dose-dependent range was tested

Model: Collagenase-induced intracerebral haemorrhage; in vitro work used lipopolysaccharide-stimulated BV-2 cells and primary microglia

Pinocembrin dose-dependently reduced lesion volume by approximately 47.5% and reduced neurological deficits at 72 hours after collagenase-induced intracerebral haemorrhage. The optimal dose of 5 mg/kg suppressed microglial activation, reduced CD68-positive microglia and proinflammatory cytokines, a…

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.